| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.072 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.6 |